Curatio, a Digital Health Company That Has Developed the World’s First Social

Health Prescription to Tackle Loneliness and Isolation, Has Raised a Series A

Round

Curatio, a digital health company that has developed the world’s first social health prescription to
tackle loneliness and isolation, has raised a Series A round. The round was led by Rhino Ventures, a
Vancouver-based venture capital firm, with participation from Conexus Venture Capital Fund.
Curatio provides health organizations their own private social networks for patients using a privacy
and regulatory compliant software platform. The amount of funding has not been disclosed.

Vancouver, Canada, May 28, 2020 --(PR.com)-- Curatio, a digital health company that has developed the
world’s first social health prescription to tackle loneliness and isolation, has raised a Series A round. The
amount of funding has not been disclosed.

The round was led by Rhino Ventures, a Vancouver-based venture capital firm, with participation from
Conexus Venture Capital Fund. Used in over 85 countries and available in 5 languages, Curatio provides
health organizations with a way to create their own private social networks for patients using a privacy
and regulatory compliant software platform. With this new funding, Curatio will continue its global
expansion and grow their team to help meet substantial pent up demand from the healthcare sector.

“Right now, the entire world is experiencing the type of isolation that millions of patients face every day.
We know that when patients and their families are provided with peer support and daily disease
management tools they have improved health outcomes, higher adherence, and better quality of life. What
we have built at Curatio is a way to deliver that type of support at scale on a platform that is designed for
the highest level of privacy and regulatory compliance required by healthcare. With COVID-19, Curatio’s
solution is needed to keep patients healthy at home and help healthcare organizations rapidly transition to
virtual delivery.” - Lynda Brown-Ganzert, Curatio CEO & Co-Founder

Rhino Ventures is known for investing early in audacious founders tackling problems with asymmetric
market potential. They were compelled by the unique needs of a vertical-specific social network vs.
incumbent solutions and, after becoming acquainted with the Curatio team and the important problem
they are solving, it became evident that Curatio’s platform undeniably leads to better patient outcomes,
which they believe is the ultimate measure for success.

“The combination of rapidly evolving market needs, an exceptional team, and their proven ability to
partner with world-class healthcare organizations makes us very excited to be working with Curatio. On a
more human level, we deeply believe in Curatio’s mission of “no patient alone”; our belief is that the
future of patient therapy is omni-channel: physical, pharmaceutical, and digital.” - Fraser Hall, Rhino
Managing Partner

Founded in 2013 by Lynda Brown-Ganzert and Alireza Davoodi, the company licenses their platform to
hospitals, insurers, research organizations, patient advocacy groups, non-profits, and pharmaceutical
manufacturers around the world that are desperately in need of virtual healthcare solutions, especially

Page 1/3
PR.com Press Release Distribution Terms of Use
during COVID-19. Used by some of the largest healthcare companies in the world, Curatio has won
numerous awards and widespread industry recognition for the way it combines social support and disease
management with AI, machine learning, and virtual patient monitoring.

“Now more than ever, we need to provide people with better ways to connect through digital options,
particularly those going through a health challenge. We are thrilled to be backing a world class founder in
Lynda Brown-Ganzert and an incredible team that’s at the forefront of healthcare transformation.” - Sean
O’Connor, Conexus Fund Manager

About Curatio: Curatio enables payers, providers, researchers and pharmaceutical manufacturers to
compliantly engage with patients on their own social networks. Used in 85 countries, available in 5
languages, Curatio has won numerous awards and recognition for its unique technical solution and its
mission of No Patient Alone.

About Rhino Ventures: Rhino Ventures is a venture capital firm that leads early-stage financings for
companies based in Western Canada. They’ve invested in 16 companies across two funds and have
~$50M AUM. Rhino Ventures is led by partners Fraser Hall, Dan Eisenhardt, and Jay Rhind, and is based
in Vancouver, BC.

About Conexus Venture Capital Inc.: Conexus Venture Capital Inc. is a Regina based fund manager,
founded by Conexus Credit Union to bring together a variety of partners and investors eager to build
Saskatchewan’s entrepreneurial ecosystem. The Limited Partner base, all entirely from Saskatchewan,
represent a strong mix of credit unions, individual business leaders, and a Saskatchewan-based retail
venture fund with approximately 28,000 Saskatchewan-based shareholders. Our Limited Partners
collectively believe that the momentum in the Saskatchewan startup ecosystem will produce outsized
returns for our investors and communities.

Page 2/3
PR.com Press Release Distribution Terms of Use
Contact Information:
Curatio
Lynda Brown-Ganzert
604-340-7997
Contact via Email
https://curatio.me
Book a demo: www.curatio.me/book-demo

Online Version of Press Release:

You can read the online version of this press release at: https://www.pr.com/press-release/813585

News Image:

Page 3/3
PR.com Press Release Distribution Terms of Use